Advanced or Refractory Solid Malignancies
1 clinical trials · Condition
◉ Watch Advanced or Refractory Solid Malignancies
| Record | Firm | Date |
|---|---|---|
| A Pivotal Bioequivalence Study of DOXIL/CAELYX (Doxorubicin HCL) in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian Cancer (NCT01815294) | Janssen Research & Development, LLC | 2013-05-01 |
Track Advanced or Refractory Solid Malignancies automatically
Every clearance here is in the API, with alerts when new ones post.